[1]韩秀蕊,杨娣娣,李艳春,等.多发性骨髓瘤患者骨髓涂片与骨髓活检同步检查的比较分析[J].现代检验医学杂志,2015,30(03):129-132.[doi:10.3969/j.issn.1671-7414.2015.03.039]
　HAN Xiu-rui,YANG Di-di,LI Yan-chun,et al.Comparative Analysis of Bone Marrow Smears and Biopsies Synchronous Check for Myeloma Patients[J].Journal of Modern Laboratory Medicine,2015,30(03):129-132.[doi:10.3969/j.issn.1671-7414.2015.03.039]
点击复制

多发性骨髓瘤患者骨髓涂片与骨髓活检同步检查的比较分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年03期
页码:
129-132
栏目:
研究简报·实验技术
出版日期:
2015-06-10

文章信息/Info

Title:
Comparative Analysis of Bone Marrow Smears and Biopsies Synchronous Check for Myeloma Patients
文章编号:
1671-7414(2015)03-129-04
作者:
韩秀蕊1; 杨娣娣1; 李艳春1; 赵 园1; 张丽洁1; 王九菊1; 魏绪仓1; 周家琛2
1.陕西省人民医院血液病研究室,西安 710068;
2.大连医科大学,辽宁大连 队16044
Author(s):
HAN Xiu-rui; YANG Di-di; LI Yan-chun; ZHAO Yuan; ZHANG Li-jie; WANG Jiu-ju; WEI Xu-cang;  ZHOU Jia-chen2
1.Department of Hematology,Shaanxi Provincal People's Hospital,Xi'an 710068,China;
2.Dalian Medical University,Liaoning Dalian 116044,China
关键词:
多发性骨髓瘤;  骨髓涂片;  骨髓活检;  浆细胞
分类号:
R446.113
DOI:
10.3969/j.issn.1671-7414.2015.03.039
文献标志码:
A
摘要:
目的 旨在了解骨髓涂片及活检在多发性骨髓瘤诊断与疗效判断中的优势与不足,明确骨髓涂片与活检同步检查在多发性骨髓瘤诊断以及治疗观察中的价值。方法 采用二步抽吸-活检双标本取材术,获取骨髓涂片及活检标本,回顾分析283例多发性骨髓瘤患者的骨髓涂片及活检结果,对骨髓增生程度、骨髓瘤细胞形态、浆细胞浸润度、增殖模式、骨髓间质病理改变及纤维化情况进行比较研究。结果 多发性骨髓瘤患者骨髓活检的增生程度及浆细胞浸润度明显高于涂片,差异有统计学显著性意义(P＜0.01); 骨髓活检对多发性骨髓瘤诊断的敏感度高于涂片,两者差异有统计学意义(P＜0.05); 骨髓活检中浆细胞增殖模式:簇片结节型33例(11.66%)、间质型86例(30.39%)、结节间质型112例(39.58%)、弥漫塞实型52例(18.37%); 骨髓涂片中骨髓瘤细胞形态:小成熟浆细胞型77例(27.21%)、幼稚浆细胞型148例(52.30%)、原始浆细胞型36例(12.72%)、网状浆细胞型22例(7.77%)。结论 骨髓活检能够准确地反映骨髓增生程度、浆细胞增殖模式及浸润度、骨髓纤维化情况; 骨髓涂片骨髓瘤细胞形态清晰、特征典型,容易辨认。骨髓涂片与活检同步检查能够提高多发性骨髓瘤诊断的敏感度及准确率,对于多发性骨髓瘤的诊断、治疗观察具有十分重要的意义。
Abstract:
Objective The purpose of this paper is to understand the advantages and disadvantages of the bone marrow smears and bone marrowbiopsy in multiple myeloma diagnosis and efficacy judgment, explicit the value of bone marrow smears and bone marrow biopsy synchronous check in the diagnosis and treatment observation of multiple myeloma.Methods With two step-suction two biopsy specimens assay,obtained specimens of bone marrow smears and bone marrow biopsy,retrospectively analysed results of 283 multiple myeloma patients bone marrow smear and biopsy,and made a comparative studyon the degree of bone marrow hyperplasia,myeloma cell morphology,the degree of tumor cell infiltration,proliferation pattern,bone marrow stromal pathological changes,and fibrosis cases.Results The degree of proliferation of bone marrow biopsy sections and infiltration of plasma cells was significantly higher than that of bone marrow smears,statistically there was a significant difference(P＜0.01).Multiple myeloma diagnostic sensitivity bybone marrow biopsy sections was significantly higher than by the bone marrow smears,the difference was statistically significant(P＜0.05).Plasma cellsin bone marrow biopsy tumor proliferation modes:clusterpiece nodular type 33 cases(11.66%),interstitial-type 86 cases(30.39%),among nodular interstitialtype 112 cases(39.58%),diffuse cypriot real 52 cases(18.37%).Plasma cellsin bone marrow smears tumor morphology:small mature plasma cell type 77 cases(27.21%),immature plasma cell type 148 cases(52.30%),protoplasmic cell type36 cases(12.72%),reticular plasma cell type 22 cases(7.77%).Conclusion Marrow biopsy can accurately reflect the degree of bone marrow hyperplasia,plasma cell tumor proliferation mode and infiltration degree,myelofibrosis situation; bone marrow smears Wright-Giemsa staining,plasma celltumor morphology was clear,typicalfeatured,and easily identifiable.Bone marrow smear and biopsy synchronous check can improve the sensitivity and accuracy for multiple myeloma diagnosis,which has very important significance for multiple myeloma diagnosis and treatment observation.

参考文献/References:

[1] 张之南,沈 悌.血液病诊断及疗效标准[M].3版.北京:科学出版社,2007:232.
Zhang ZN,Shen T.Blood disease diagnostic and curative standard[M].3th Ed.Beijing:Science Press,2007:232.
[2] 蒲 权,杨梅如.血液病骨髓诊断病理学[M].北京:科学出版社,2002:4-342.
Pu Q,Yang MR.Diagnostc pathology of the bone marrow in hematology[M].Beijing:Science Press,2002:4-342.
[3] 蒲 权.实用血液病理学[M].北京:科学出版社,2013:62,494-495.
Pu Q.Practical hematopathology[M].Beijing:Science Press,2013:62,494-495.
[4] 赵应斌,吕桂桦,丁燕玲,等.多发性骨髓瘤细胞形态学分型分析[J].现代检验医学杂志,2006,21(1):57-58.
Zhao YB,L(¨overu)GH,Ding YL,et al.Multiple myeloma cells formfor credit analysis[J].Journal of Modern Laboratory Medicine,2006,21(1):57-58.
[5] Ludwig H,Durie BG,Bolejack V,et al.Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival:ananalysis of 10 549 patients form the International Myeloma Working Group[J].Blood,2008,111(8):4039-4047.
[6] Terpstra WE,Lokhorst HM,Blomjous F,et al.Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patient with multiple myeloma[J].Br J Haematol,1992:82(1):46-49.
[7] Basak GW,Srivastava AS,Malhotra R,et al.Multiple myeloma bone marrowniche[J].Curr Pharm Biotechnol,2009,10(3):345-346.
[8] 苏基滢,陶 英,刘薏芝,等.多发性骨髓瘤骨髓活检切片与涂片的比较[J].中国实验血液学杂志,2012:20(6):1389-1391.
Su JY,Tao Y,Liu YZ,et al.Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma[J].Journal of Experimental Hematology,2012:20(6):1389-1391.
[9] Stifter S,Babarovic E,Valkovic T,et al.Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma[J].Diagn Pathol,2010(5):30.

相似文献/References:

[1]张宇洋,孙雪静.骨髓穿刺涂片联合骨髓活检切片在骨髓增生异常综合征诊断中的应用[J].现代检验医学杂志,2016,31(02):139.[doi:10.3969/j.issn.1671-7414.2016.02.042]
　ZHANG Yu-yang,SUN Xue-jing.Value of Both Bone Marrow Biopsy and Smear in Diagnosis of Myelodysplastic Syndrome[J].Journal of Modern Laboratory Medicine,2016,31(03):139.[doi:10.3969/j.issn.1671-7414.2016.02.042]
[2]邱 爽,孟瑞芳,蒋筱漪,等.血清免疫固定电泳、蛋白电泳、免疫球蛋白及轻链定量在诊断多发性骨髓瘤中的临床应用[J].现代检验医学杂志,2015,30(02):61.[doi:10.3969/j.issn.1671-7414.2015.02.019]
　QIU Shuang,MENG Rui-fang,JIANG Xiao-yi,et al.Clinical Application of Immunofixtion Electrophoresis, Serum Protein Electrophoresis and Immunoglobulins and Light Chain Quantitative Analysis in the Diagnosis of Multiple Myeloma[J].Journal of Modern Laboratory Medicine,2015,30(03):61.[doi:10.3969/j.issn.1671-7414.2015.02.019]
[3]李 瑛,李 军.多发性骨髓瘤患者血清中IL-6与IL-27水平监测的临床应用[J].现代检验医学杂志,2016,31(04):87.[doi:10.3969/j.issn.16717-414.2016.04.023]
　LI Ying,LI Jun.Clinical Application of Monitoring IL-6 and IL-27 Levels in Patients with Multiple Myeloma[J].Journal of Modern Laboratory Medicine,2016,31(03):87.[doi:10.3969/j.issn.16717-414.2016.04.023]
[4]郭进京,胡林辉,陶千山,等.红细胞分布宽度在多发性骨髓瘤患者预后分期中的价值[J].现代检验医学杂志,2017,32(03):34.[doi:10.3969/j.issn.1671-7414.2017.03.009]
　GUO Jin-jing,HU Lin-hui,TAO Qian-shan,et al.Value of Red Cell Distribution Width in the Prognosis of Patients with Multiple Myeloma[J].Journal of Modern Laboratory Medicine,2017,32(03):34.[doi:10.3969/j.issn.1671-7414.2017.03.009]
[5]谭 奎,沈婵娟,张 玲,等.多发性骨髓瘤患者骨髓CD269和CD317基因的差异性表达研究[J].现代检验医学杂志,2017,32(06):64.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　TAN Kui,SHEN Chan-juan,ZHANG Ling,et al.Differential Expression of CD269 and CD317 Genes in Bone Marrow of Patients with Multiple Myeloma[J].Journal of Modern Laboratory Medicine,2017,32(03):64.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[6]盘国雄,谭才燕,何嘉颖,等.多发性骨髓瘤患者血清中lncRNA PCAT-1的表达水平与临床预后研究[J].现代检验医学杂志,2018,33(01):72.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　PAN Guo-xiong,TAN Cai-yan,HE Jia-ying,et al.Serum LncRNA PCAT-1 Expression Level of Patients with Multiple Myeloma and Clinical Value[J].Journal of Modern Laboratory Medicine,2018,33(03):72.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[7]刘玉霞,胡国瑜,袁朝晖,等.CD269和CD317在多发性骨髓瘤中的表达及临床意义[J].现代检验医学杂志,2018,33(02):58.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　LIU Yu-xia,HU Guo-yu,YUAN Chao-hui,et al.Expression of CD269 and CD317 in Multiple Myeloma and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2018,33(03):58.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[8]张 蓉,李国辉,刘小五,等.初诊多发性骨髓瘤患者外周血淋巴细胞绝对值/ 单核细胞绝对值比值在预测临床预后的价值研究[J].现代检验医学杂志,2020,35(01):101.[doi:10.3969/j.issn.1671-7414.2020.01.027]
　ZHANG Rong,LI Guo-hui,LIU Xiao-wu,et al.Value of Peripheral Blood Lymphocyte Absolute Value/Monocyte Absolute Value Ratio in Predicting Clinical Prognosis of Newly Diagnosed MultipleMyeloma Patients[J].Journal of Modern Laboratory Medicine,2020,35(03):101.[doi:10.3969/j.issn.1671-7414.2020.01.027]
[9]霍 豆,秦 爽,吴永昌,等.血清总轻链与游离轻链定量检测在多发性骨髓瘤诊断中的临床价值探讨[J].现代检验医学杂志,2020,35(04):87.[doi:10.3969/j.issn.1671-7414.2020.04.021]
　HUO Dou,QIN Shuang,WU Yong-chang,et al.Clinical Value of Quantitative Detection of sTLC and sFLC in Diagnosis of Multiple Myeloma[J].Journal of Modern Laboratory Medicine,2020,35(03):87.[doi:10.3969/j.issn.1671-7414.2020.04.021]
[10]何　进,张　艳,申娴娟,等.多发性骨髓瘤患者血清可溶性PD-L1水平在辅助诊断及临床分型的价值研究[J].现代检验医学杂志,2021,36(02):15.[doi:doi:10.3969/j.issn.1671-7414.2021.02.004]
　HE Jin,ZHANG Yan,SHEN Xian-juan,et al.Value of Blood Soluble PD-L1 in the Auxiliary Diagnosis and Clinical Subtype of Multiple Myeloma[J].Journal of Modern Laboratory Medicine,2021,36(03):15.[doi:doi:10.3969/j.issn.1671-7414.2021.02.004]

备注/Memo

备注/Memo:
作者简介:韩秀蕊(1963-),女,本科,副主任技师,从事血液病实验诊断与研究工作。
通讯作者:魏绪仓,研究员,Tel:029-85251331-2371:E-mail:weixucang62@sina.com。
更新日期/Last Update: 2015-06-10